Frederick National Laboratory for Cancer Research

Home
United States
Frederick, MD
Frederick National Laboratory for Cancer Research

Call Directions Website

Leidos Biomed operates the Frederick National Laboratory for Cancer Research, sponsored by the National Cancer Institute.

Leidos Biomed operates the Frederick National Laboratory for Cancer Research, a U.S. national lab focused on discovery and innovation in biomedical science and rapid response to emerging infectious diseases. Sponsored by the National Cancer Institute, the laboratory collaborates with public and private partners to solve urgent and intractable problems in biomedical science. We conduct investigator-initiated, hypothesis-driven research -- with a focus on cancer and AIDS -- and maintain an integrated suite of leading-edge biomedical technologies as shared national resources. Our scientific expertise is broad and deep, covering genetics, genomics, protein science, proteomics, bioinformatics, immunology, high-performance biomedical computing, nanotechnology, biopharmaceutical manufacturing, laboratory animal sciences, and clinical operations. The Frederick National Lab is headquartered in Frederick, Md., 50 miles north of Washington, D.C.

11/03/2026

How does molecular diagnostic testing bridge the gap between bench and bedside in cancer and disease-related research? How can molecular diagnostic testing be more accessible? Join us on Thursday, Nov. 12 as our speakers for the next Biotech Connector explore these questions and more!

This hybrid event is co-hosted with the Frederick County Chamber of Commerce to bring together the local and regional biotech community.

Learn more and register today: https://heyor.ca/ykghX6

11/02/2026

This Pancreatic Cancer Awareness Month, take a closer look at the science... one cell at a time. By studying individual tumor cells, researchers are uncovering how pancreatic cancer evolves and how cells within the same tumor can differ genetically. These insights could help inform future research on treatment response and resistance.

Explore the science in this : https://heyor.ca/yoUs2K

The RAS Dialogue Blog posts are written by RAS experts sharing the latest research, updates, and scientific RAS news. The content is curated by the RAS Initiative.

10/29/2026

the Antibody Characterization Laboratory provides antibody validation as a community resource overseen by the National Cancer Institute’s Office of Cancer Clinical Proteomics Research?

Using a range of characterization techniques, the laboratory evaluates antibodies and other renewable reagents to support their use in cancer research.

Explore the available data standards, reference materials, and resources online: https://heyor.ca/u5MlMz

10/28/2026

Scientists in our Protein Expression Laboratory develop high-quality proteins, DNA and cell line reagents, along with innovative technologies designed to tackle challenging protein targets.

Their expertise supports research across structural biology, assay development, drug discovery and national research initiatives – helping turn complex scientific questions into meaningful progress.

Explore the Protein Expression Laboratory and its capabilities: https://heyor.ca/Sr4euB

10/21/2026

Did you catch our latest Biotech Connector? Three local HIV/AIDS researchers shared their work exploring new approaches to achieving a lasting treatment for HIV. Each took a different approach to tackling the HIV cure challenge, focusing on different parts of the immune system: CD8+ T cells, CD4 cells and B cells. Read the full recap: https://heyor.ca/DQLtHC

📅 Don’t miss the next Biotech Connector on November 12 at 8 a.m. We hope to see you there!

10/08/2026

We're hiring! Join the team at the Frederick National Laboratory for Cancer Research and bring your skills to work that supports an important mission: Discovery, innovation, and success in the biomedical sciences.

We’re currently recruiting for several opportunities:

🔹 Molecular Pathologist / CLIA Director - MoCha: https://heyor.ca/7slPSy

🔹 RO Water Systems Specialist: https://heyor.ca/4sV7I9

🔹 Boiler Operator-MD Grade I: https://heyor.ca/qa7K0A

🔹 Service Worker: https://heyor.ca/nnGDEj

🔹 Lab Animal Caretaker II: https://heyor.ca/4gGq5k

🔹 Laboratory Animal Caretaker II: https://heyor.ca/x5PK74

10/07/2026

📢 One week away! Register for our next Project Management Night Out seminar at Hood College on October 14: https://heyor.ca/gvq43N

During this event, Kate Vendemio, PMP and founder and CEO of Mt. Vernon Consulting, LLC, will tackle one of the toughest parts of project management: keeping people motivated when so much of it is out of your control.

10/07/2026

It’s Day 1 of the sixth Initiative Symposium! Stop by the National Cryo-EM Facility (NCEF) booth to say hello and learn how NCEF supports the cancer research community with expert data collection and access to advanced cryo-EM instrumentation.

Two Titan Krios instruments at NCEF are fully dedicated to serving cancer researchers at extramural nonprofit and academic institutions. This service is provided at no cost. Applicants do not need to hold an NIH grant to apply: https://heyor.ca/w3gVUd

📢 Coming later this fall: NCEF will also launch new Sample Grid Preparation Services designed to support labs with limited cryo-EM infrastructure.

We hope you’ll stop by and learn more!

10/06/2026

Thank you to KPCW Radio for hosting Raj Chari, laboratory director and senior investigator at the Frederick National Laboratory for Cancer Research!

Raj joined the show to discuss how researchers are using gene-editing technologies to deepen our understanding of cancer and explore new therapeutic approaches. He also shares how gene editing is being used in the lab today, where it shows the greatest promise in cancer research, and how these advances could ultimately benefit patients.

Tune in to hear Raj’s full conversation and learn more about the potential of gene editing to transform cancer research and treatment: https://heyor.ca/yldL4W

Gene-editing researcher Raj Chari discusses how CRISPR technology is being used to study cancer, develop potential new treatments, and explore the challenges of bringing gene-editing therapies from the laboratory into clinical care.

09/30/2026

🔬 Employee Spotlight: Meet Samantha!

Samantha is a Clinical Study Coordinator in the Clinical Research Directorate whose work spans the lab, clinic and clinical trial operations within NIAID’s Laboratory of Immunoregulation. Her role helps connect immune research with patient care, particularly for infectious and inflammatory diseases.�

In the lab, Samantha studies how patients’ immune systems respond during illness by analyzing immune cells from blood samples. Her work can help identify how those cells are functioning and detect signs of inflammation in conditions in which the immune system can become dangerously overactive. Beyond the lab, she meets with patients in the clinic and helps support clinical trial operations.

One of the most rewarding parts of her work is serving as a “bench to bedside” liaison between researchers and clinicians. By helping physicians understand what’s happening at the cellular level, Samantha’s laboratory work can provide additional insight into a patient’s immune response and help connect scientific findings with patient care.

Learn more about our Clinical Research Directorate 👉 https://heyor.ca/3l3lae

Address

8560 Progress Drive
Frederick, MD
21701

Telephone

+13018461000

Website

http://frederick.cancer.gov/

Alerts

Be the first to know and let us send you an email when Frederick National Laboratory for Cancer Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.